These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21571316)

  • 1. Expression of the active Notch1 decreases MTC tumor growth in vivo.
    Jaskula-Sztul R; Pisarnturakit P; Landowski M; Chen H; Kunnimalaiyaan M
    J Surg Res; 2011 Nov; 171(1):23-7. PubMed ID: 21571316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
    Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
    Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
    Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
    Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
    Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
    Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
    Kunnimalaiyaan M; Ndiaye M; Chen H
    Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.
    Truong M; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2011 May; 18(5):1506-11. PubMed ID: 21184191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.
    Starenki D; Hong SK; Lloyd RV; Park JI
    Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
    Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R
    Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.
    Yu XM; Phan T; Patel PN; Jaskula-Sztul R; Chen H
    Cancer; 2013 Feb; 119(4):774-81. PubMed ID: 22991264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.
    Jaskula-Sztul R; Eide J; Tesfazghi S; Dammalapati A; Harrison AD; Yu XM; Scheinebeck C; Winston-McPherson G; Kupcho KR; Robers MB; Hundal AK; Tang W; Chen H
    Mol Cancer Ther; 2015 Feb; 14(2):499-512. PubMed ID: 25512616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
    Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
    Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer.
    Vaccaro A; Chen H; Kunnimalaiyaan M
    Anticancer Drugs; 2006 Aug; 17(7):849-53. PubMed ID: 16926634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
    Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide suppresses growth in human medullary thyroid cancer cells.
    Alhefdhi A; Burke JF; Redlich A; Kunnimalaiyaan M; Chen H
    J Surg Res; 2013 Nov; 185(1):212-6. PubMed ID: 23816245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer Cells.
    Ishii J; Yazawa T; Chiba T; Shishido-Hara Y; Arimasu Y; Sato H; Kamma H
    Endocrinology; 2016 Mar; 157(3):1289-98. PubMed ID: 26760117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
    Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
    Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.
    Wael H; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T
    Lung Cancer; 2014 Aug; 85(2):131-40. PubMed ID: 24888228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation.
    Carson EB; McMahon M; Baylin SB; Nelkin BD
    Cancer Res; 1995 May; 55(10):2048-52. PubMed ID: 7743500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.